000			02115 a2200577 4500
005			20250515054457.0
264		0	_c20070316
008			200703s 0 0 eng d
022			_a0361-1817
024	7		_a10.1097/00006205-200702000-00009 _2doi
040			_aNLM _beng _cNLM
100	1		_aLaustsen, Gary
245	0	0	_aDrug approvals. _h[electronic resource]
260			_bThe Nurse practitioner _cFeb 2007
300			_a43-51; quiz 51-2 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcetanilides _xtherapeutic use
650	0	4	_aAlprostadil _xanalogs & derivatives
650	0	4	_aAngina Pectoris _xdrug therapy
650	0	4	_aBenzazepines _xtherapeutic use
650	0	4	_aBone Density Conservation Agents _xtherapeutic use
650	0	4	_aDiphosphonates _xtherapeutic use
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Approval _xstatistics & numerical data
650	0	4	_aDrug Therapy _xnursing
650	0	4	_aDrug-Related Side Effects and Adverse Reactions
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aFatty Acids _xtherapeutic use
650	0	4	_aHerpes Zoster Vaccine _xstandards
650	0	4	_aHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
650	0	4	_aHumans
650	0	4	_aIbandronic Acid
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aLubiprostone
650	0	4	_aNaltrexone _xtherapeutic use
650	0	4	_aNarcotic Antagonists _xtherapeutic use
650	0	4	_aNurse's Role
650	0	4	_aPapillomavirus Vaccines _xstandards
650	0	4	_aPatient Education as Topic
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aQuinoxalines _xtherapeutic use
650	0	4	_aRanolazine
650	0	4	_aTriazoles _xtherapeutic use
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
650	0	4	_aVarenicline
700	1		_aGilbert, Marcia
700	1		_aWimett, Lynn
773	0		_tThe Nurse practitioner _gvol. 32 _gno. 2 _gp. 43-51; quiz 51-2
856	4	0	_uhttps://doi.org/10.1097/00006205-200702000-00009 _zAvailable from publisher's website
999			_c16826034 _d16826034